AI-designed drug slowed biological aging in study
Both outlets reported that an AI-designed drug, rentosertib, appeared to slow biological aging in a study involving 43 patients. The News International added the detail that the drug was developed by Insilico Medicine, while Minute Mirror omitted this information. Otherwise, the framing and emphasis were nearly identical, with both highlighting the consistent results across six aging clocks.
Summary generated by HarZaviya from the headlines and excerpts of the 2 outlets below. Each outlet's own headline is listed under it.
Same story from 2 outlets
Each outlet's own headline, most recent first — read any at its source.
-
AI-designed drug slowed biological ageing
Six separate ageing clocks, run on the same 43 patients, all pointed in the same direction: a younger predicted biological age after 12 weeks on an experimental drug.
-
AI-designed drug also slowed biological aging, study finds
Six separate ageing clocks, run on the same 43 patients, all pointed in the same direction: younger predicted biological age after 12 weeks on an experimental drug. The drug, rentosertib, was built by Insilico Medicine to treat idiopathic...
2 articles from 2 outlets, 7 Sep–7 Sep 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?